Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis.
Saved in:
| Title: | Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis. |
|---|---|
| Authors: | Antonia, Scott J1 (AUTHOR) scott.antonia@duke.edu, Borghaei, Hossein2 (AUTHOR), Ramalingam, Suresh S3 (AUTHOR), Horn, Leora4 (AUTHOR), De Castro Carpeño, Javier5 (AUTHOR), Pluzanski, Adam6 (AUTHOR), Burgio, Marco A7 (AUTHOR), Garassino, Marina8 (AUTHOR), Chow, Laura Q M9 (AUTHOR), Gettinger, Scott10 (AUTHOR), Crinò, Lucio7 (AUTHOR), Planchard, David11 (AUTHOR), Butts, Charles12 (AUTHOR), Drilon, Alexander13 (AUTHOR), Wojcik-Tomaszewska, Joanna14 (AUTHOR), Otterson, Gregory A15 (AUTHOR), Agrawal, Shruti16 (AUTHOR), Li, Ang16 (AUTHOR), Penrod, John R16 (AUTHOR), Brahmer, Julie17 (AUTHOR) |
| Source: | Lancet Oncology. Oct2019, Vol. 20 Issue 10, p1395-1408. 14p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
